Nascent signs of renewed investor interest in physician practice deals could bolster private-equity exits in 2025.

PE firms that can't unload portfolio companies through an IPO or sale are turning to an increasingly popular alternative.

Here are what three ASC leaders outlined as pros and cons of private equity in the ASC industry: Editor's note: Responses have been lightly edited for clarity and length.

Thoma Bravo takes an ownership stake in Opexus. The seller of process management software plans to integrate Casepoint’s data ...

A coalition of pension managers and other institutional investors have issued a fresh call for PE fund managers to clearly ...

Arctos Partners secured a 10% minority investment in the Buffalo Bills—the biggest share the NFL allows PE firms to hold ...